ログイン
ランキング
お知らせ
ログイン
文献詳細
綜説
文献概要
要旨 腎移植後の感染症は，移植腎の生着率に影響を与えるばかりでなく，重篤な場合にはレシピエントの生命に危険をもたらすので，腎移植に携わる泌尿器科医は感染症について十分な知識を持たなければならない。腎移植における感染症のコントロールは，①ドナーの潜在的な感染症を持ち込ませないこと，②レシピエントの潜在的な感染症を移植前に治療しておくこと，③レシピエントにはワクチン接種を術前に確実に行うこと，④腎移植後の時期によって，起こりやすい感染症を認識し，予防または早期診断・早期治療に務めることが重要である。
参考文献
1）Grim SA and Clark NM：Management of infectious complications in solid-organ transplant recipients. Clin Pharmacol Ther 90：333-42, 2011
2）Parasuraman R, Samarapungavan D and Venkat KK：Updated principles and clinical caveats in the management of infection in renal transplant recipients. Transplant Rev 24：43-51, 2010
3）山口一成：感染症の話．国立感染症研究所感染症情報センター・感染症発生調査動向週報（2011年第7号）http://idsc.nih.go.jp/idwr/kansen/k2011/2011-07/2011k07.html
4）国立国際医療センター・肝炎情報センター：B型肝炎について．http://www.ncgm.go.jp/center/forcomedi_hbv.html
5）上田佳秀：ウィルス感染症B型肝炎ウィルス．腎移植・血管外科21：177-183，2009
6）国立国際医療センター・肝炎情報センター：C型肝炎およびにC型肝炎ウイルスとは．http://www.ncgm.go.jp/center/forcomedi_hcv.html
7）Alangaden GJ, Thyagarajan R, Gruber SA, et al：Infectious complications after kidney transplantation：current epidemiology and associated risk factors. Clin Transplant 20：401-409, 2006
8）Ho M：Epidemiology of cytomegalovirus infections. Rev Infect Dis 12（Suppl 7）：S701-710, 1990
9）Niscola P, Del Principe MI, Maurillo L, et al：Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Leukemia 19：1840-1841, 2005
10）Law JK, Ho JK, Hoskins PJ, et al：Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient：potential implications for future prophylaxis recommendations. Leuk Lymphoma 46：1085-1089, 2005
11）Ouseph R, Eng M, Ravindra K, et al：Review of the use of hepatitis B core antibody-positive kidney donors. Transplant Rev（Orlando）24：167-171, 2010
12）Madayag RM, Johnson LB and Bartlett ST：Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 64：1781-1786, 1997
13）Nahar K, Jahan M, Nessa A, et al：Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients. Bangladesh Med Res Counc Bull 37：88-91, 2011
14）田中英夫：我が国における肝細胞癌の疫学動向．日本臨床67：263-267，2009
15）Nakai S, Masakane I, Shigematsu T, et al：An overview of regular dialysis treatment in Japan（As of 31 December 2007）. Ther Apher Dial 13：457-504, 2009
16）日本肝臓学会・肝炎診療ガイドライン作成委員会：C型肝炎治療ガイドライン（第1版）．http://www.jsh.or.jp/medical/date/240510_Cguideline.pdf
17）社団法人日本透析医学会：透析患者のC型ウィルス肝炎治療ガイドライン．透析会誌44：481-531，2011
18）Maluf DG, Archer KJ and Mas VR：Kidney grafts from HCV-positive donors：advantages and disadvantages. Transplant Proc 42：2436-2446, 2010
19）Morales JM, Campistol JM, Domínguez-Gil B, et al：Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant 10：2453-2462, 2010
20）Domínguez-Gil B, Andrés A, Campistol JM, et al：Should we be using kidneys from hepatitis C virus-infected donors? Curr Opin Nephrol Hypertens 20：599-604, 2011
21）Kharfan-Dabaja MA, Boeckh M, Wilck MB, et al：A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation：a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12：290-299, 2012
22）Robertson S, Newbigging K, Carman W, et al：Scottish Renal Registry：Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient：should renal patients be vaccinated against VZV before transplantation? Clin Transplant 20：136-138, 2006
23）Bensousan TA, Moal MC, Vincent F, et al：Fulminant hepatitis revealing primary varicella in a renal graft recipient. Transplant Proc 27：2512, 1995
24）Pergam SA and Limaye AP：AST Infectious Diseases Community of Practice：Varicella Zoster Virus（VZV）in solid organ transplant recipients. Am J Transplant 9（Suppl 4）：S108-115, 2009
25）根岸康介，秋山由里香，竹田 亮，他：結核を合併した末期腎不全患者の臨床的検討．日腎会誌44：319，2002
TB-2Gの有用性について．日本透析医学会雑誌41：65-70，2008
27）Fishman JA and Davis JA：Infection in renal transplant recipients. In：Kidney Transplantation. edited by Morris PJ, Knechtle SJ. Saunders, Philadelphia, p494, 2008
28）Siegel JD, Rhinehart E, Jackson M, et al：The Healthcare Infection Control Practices Advisory Committee：2007 Guideline for isolation precautions：preventing transmission of infectious agents in healthcare settings. http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html
29）日本泌尿器科学会泌尿器科領域における感染制御ガイドライン作成委員会：泌尿器科領域における感染制御ガイドライン．日泌尿会誌10：1-27，2009
30）Leonardou P, Gioldasi S, Zavos G, et al：Mycotic pseudoaneurysms complicating renal transplantation：a case series and review of literature. J Med Case Rep 6：59, 2012
31）Hecker MT, Aron DC, Patel NP, et al：Unnecessary use of antimicrobials in hospitalized patients：current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 163：972-978, 2003
32）Lapchik MS, Castelo FA, Pestana JO, et al：Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients：a matched-pair case-control study. J Urol 147：994-998. 1992
33）Avery RK：Infectious disease following kidney transplant：core curriculum 2010. Am J Kidney Dis 55：755-771, 2010
34）Parasuraman R, Samarapungavan D and Venkat KK：Updated principles and clinical caveats in the management of infection in renal transplant recipients. Transplant Rev（Orlando）24：43-51, 2010
35）Ponticelli C and Passerini P：Gastrointestinal complications in renal transplant recipients. Transpl Int 18：643-650, 2005
36）Guerraoui A, Grezard O, Cottier JP, et al：Cytomegalovirus encephalitis in a kidney transplant recipient. Nephrol Dial Transplant 9：329-330, 1994
37）Toupance O, Bouedjoro-Camus MC, Carquin J, et al：Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients：a cohort study with case-control analyses. Transpl Int 13：413-419, 2000
38）Sagedal S, Nordal KP, Hartmann A, et al：The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2：850-856, 2002
39）Kliem V, Fricke L, Wollbrink T, et al：Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir：results of a randomized clinical trial. Am J Transplant 8：975-983, 2008
40）日本臨床腎移植学会ガイドライン作成委員会：腎移植後CMV感染症の治療薬．In：腎移植後サイトメガロウィルス感染症の診療ガイドライン2011．日本医学館，東京pp16-22，2011
41）Strippoli GF, Hodson EM, Jones C, et al：Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 81：139-145, 2006
42）Ruocco V, Sangiuliano S, Brunetti G, et al：Beyond Zoster：Sensory and Immune Changes in Zoster-affected Dermatomes Acta Derm Venereol. 2012［Epub ahead of print］
43）藤井洋輔，宮村能子，茶山公祐，他：水痘帯状疱疹ウイルスの再活性化により無疱性帯状疱疹と髄膜炎を発症した急性リンパ性白血病の1例．小児科臨床6：1111-1115，2011
44）Broekema NM and Imperiale MJ：Efficient propagation of archetype BK and JC polyomaviruses. Virology 422：235-241, 2012
45）Cannon RM, Ouseph R, Jones CM, et al：BK viral disease in renal transplantation. Curr Opin Organ Transplant 16：576-579, 2011
46）Latif S, Zaman F, Veeramachaneni R, et al：BK polyomavirus in renal transplants：role of electron microscopy and immunostaining in detecting early infection. Ultrastruct Pathol 31：199-207, 2007
47）Dheir H, Sahin S, Uyar M, et al：Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. Transplant Proc 43：867-870, 2011
48）Johnston O, Jaswal D, Gill JS, et al：Treatment of polyomavirus infection in kidney transplant recipients：a systematic review. Transplantation 89：1057-1070, 2010
49）Sánchez Fructuoso AI, Calvo N, Perez-Flores I, et al：Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients. Transpl Infect Dis 13：584-591, 2011
50）Patel HV, Kute VB, Vanikar AV, et al：Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis B surface antigen. Transplant Proc 44：72-74, 2012
51）Cosconea S, Fontaine H, Méritet JF, et al：Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection. J Hepatol, 2012［Epub ahead of print］
52）Reddy PN, Sampaio MS, Kuo HT, et al：Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States. Clin J Am Soc Nephrol 6：1481-1487, 2011
53）厚生労働省「難治性の肝・胆道疾患に関する調査研究班」「肝硬変を含めたウイルス性肝疾患の治療の標準化に関する研究班」：免疫抑制・化学療法により発症するB型肝炎対策ガイドライン（改訂版）．http://www.ryumachi-jp.com/info/news110926_gl.pdf
54）Hanafusa T, Ichikawa Y, Kishikawa H, et al：Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 27：471-476, 1998
55）Sharma RK, Bansal SB, Gupta A, et al：Chronic hepatitis C virus infection in renal transplant：treatment and outcome. Clin Transplant 20：677-683, 2006
56）Toth CM, Pascual M, Chung RT, et al：Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation：response to interferon-alpha therapy. Transplantation 66：1254-1258, 1998
57）Yamabe H, Johnson RJ, Gretch DR, et al：Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6：220-223, 1995
58）Terrault NA and Adey DB：The kidney transplant recipient with hepatitis C infection：pre-and posttransplantation treatment. Clin J Am Soc Nephrol 2：563-575, 2007
59）Kamar N, Sandres-Saune K, Selves J, et al：Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients：effects on renal function and liver histology. Am J Kidney Dis 42：184-192, 2003
60）Aljumah AA, Saeed MA, Al Flaiw AI, et al：Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 18：55-63, 2012
61）Pearlman BL：Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection：the new standard of care. Lancet Infect Dis 2012［Epub ahead of print］
62）Preiksaitis JK and Keay S：Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 33（Suppl 1）：S38-46, 2001
63）Ishihara M, Tanaka E, Sato T, et al：Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients. Clin Nephrol 76：40-48, 2011
64）Fishman JA and Davis JA：Infection in renal transplant recipients. In：Kidney Transplantation. edited by Morris PJ, Knechtle SJ. Saunders, Philadelphia, p502, 2008
65）日本移植学会：移植後患者における新型インフルエンザ対策ガイドライン．http://www.asas.or.jp/jst/pdf/guideline20090928_1.pdf
66）猪瀬悠理，秋山茂雄，望月温子，他：生体腎移植後にHTLV-1関連脊髄症を発症した1例．臨床神経学50：241-245，2010
67）Trullas JC, Cofan F, Tuset M, et al：Renal transplantation in HIV-infected patients：2010 update. Kidney Int 79：825-842, 2011
68）Jung JY, Joo DJ, Lee CH, et al：Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area. Int J Tuberc Lung Dis 16：248-254, 2012
69）Bhaloo S and Prasad GV：Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors：a case report. Transplant Proc 35：2449-2451, 2003
70）López-Montes A, Gallego E, López E, et al：Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis 44：e59-63, 2004
71）Baek CH, Yang WS, Park KS, et al：Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation. Nephron Extra 2：66-75, 2012
72）Ettrich TJ, Lübbert C, Ebelt H, et al：Septic shock in a renal transplanted patient after consumption of uncooked pork meat. Internist（Berl）52：1114-1117, 2011
73）Chadban S, Chan M, Fry K, et al；CARI：The CARI guidelines. Food safety recommendations for adult kidney transplant recipients. Nephrology（Carlton）15（Suppl 1）：S35-36, 2010
74）Yazaki H, Goto N, Uchida K, et al：Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients：P. jiroveci is contagious to the susceptible host. Transplantation 88：380-385, 2009
掲載誌情報
